Medical technology company Sky Medical secures King's Award for their innovative geko device in the enterprise category.
The geko device, developed by Sky Medical Technology, is making a significant impact in the global healthcare industry, particularly in the management of chronic wounds. This innovative device, which has been clinically proven to more than double the rate of wound healing, is gaining widespread acceptance and is being adopted at an increasing pace.
Over the last three consecutive quarters, the number of prescriptions for the geko device has risen by over 60% quarter-over-quarter. This surge in demand is a testament to the device's effectiveness in enhancing blood circulation through neuromuscular electrical stimulation, a method that contributes to the healing of chronic wounds and improves patient care.
The device, which is wearable and portable, induces muscle contractions by stimulating the peroneal nerve. This mimics natural movement, increasing circulation in the legs and other areas prone to chronic wounds, thereby supplying much-needed oxygen and nutrients for tissue repair.
Moreover, the geko device helps manage complications like swelling (edema) and venous thromboembolism, which can hinder wound healing and lead to serious health issues if left untreated. By reducing these complications, the device plays a crucial role in promoting the healing of chronic wounds such as leg ulcers.
The device's accessibility and global reach have also been boosted. Since April 2024, the geko device has been made available on the Government of India e-marketplace (GeM), allowing government hospitals across India to access it easily. This expansion of availability is a significant step in improving wound care and preventing complications related to chronic wounds and orthopedic surgery recovery on a global scale.
Clinicians are reporting an immediate reduction in pain with the use of the geko device. The portability and simplicity of the device are reducing demand on overstretched healthcare services and lowering the carbon footprint associated with frequent in-person visits and complex compression dressing changes.
Patient-reported benefits are drawing particular attention in clinical settings. Fiona Young, Firstkind Wound Therapy Business Director, commented that the geko device delivers real-world value clinically, operationally, and economically. With FDA clearance, NICE guidance, and integration across NHS Trusts and international health systems, the company claims the geko device is establishing a new standard in chronic wound management.
The geko device's rapid rate of adoption is addressing an unmet need in the healthcare industry. Chronic wounds remain a critical global health challenge, costing healthcare systems billions annually. The device's non-invasive therapy, which is demonstrating a rapid effect on healing, offers a scalable, cost-effective solution to this problem.
In summary, the geko device enhances chronic wound healing by augmenting blood flow through targeted electrical stimulation, preventing complications, and expanding global patient access. This innovation in wound care technology, which has been recognised with the King's Award for Enterprise in Innovation, is set to revolutionise the way chronic wounds are managed, improving overall patient care outcomes.
[1] Source: Sky Medical Technology press release, www.skymedical.co.uk/news [4] Source: Clinical trial results, www.ncbi.nlm.nih.gov/pubmed/34417819
1) The rise in prescriptions for the geko device demonstrates its effectiveness in patient care, particularly in managing chronic wounds, as more medical professionals adopt this innovative piece of medical technology.
2) The incorporation of medical plastics in the geko device's design allows for a wearable and portable device that stimulates the peroneal nerve, aiding in enhancing blood circulation and promoting healing of medical-conditions such as chronic wounds.
3) As technology advances, the integration of science, such as neuromuscular electrical stimulation, into healthcare solutions like the geko device, is transforming the health-and-wellness sector by offering cost-effective solutions to global health challenges like chronic wounds.
